Amgen (AMGN) Earnings Date, Estimates & Call Transcripts $328.07 -1.08 (-0.33%) (As of 09:45 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 29EstimatedActual EPS (Aug. 6) $4.97 Missed By -$0.04 Consensus EPS (Aug. 6) $5.01 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Get Amgen Earnings AlertsEnter your email address below to receive the latest news and earnings results for AMGN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAMGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMGN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsSecure this "AI Fuel" Stock Before the Billionaires Buy It AllAccording to the Washington Post, America is running out of a crucial component for AI. Without this "AI fuel," firms like NVIDIA would have to shut down their operations.Click here for the ticker >>> Amgen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244$3.64$4.86$4.10 Q2 20244$4.85$5.14$5.04 Q3 20244$4.85$5.23$5.09 Q4 20244$4.81$5.48$5.21 FY 202416$18.15$20.71$19.44 Q1 20252$4.69$4.88$4.79 Q2 20252$5.05$5.37$5.21 Q3 20252$5.30$5.34$5.32 Q4 20252$4.33$5.45$4.89 FY 20258$19.37$21.04$20.21 Q1 20261$4.80$4.80$4.80 AMGN Earnings Date and InformationAmgen last released its quarterly earnings results on August 6th, 2024. The medical research company reported $4.97 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.01 by $0.04. The company had revenue of $8.39 billion for the quarter, compared to the consensus estimate of $8.35 billion. Its quarterly revenue was up 20.1% on a year-over-year basis. Amgen has generated $7.00 earnings per share over the last year ($7.00 diluted earnings per share) and currently has a price-to-earnings ratio of 46.9. Earnings for Amgen are expected to grow by 5.69% in the coming year, from $19.50 to $20.61 per share. Amgen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 29th, 2024 based off prior year's report dates.Read More Amgen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/29/2024(Estimated)------- 8/6/2024Q2 2024$5.01$4.97($0.04)$8.56$8.35 billion$8.39 billion 5/2/2024Q1 2024$3.76$3.96+$0.20$8.13$7.45 billion$7.45 billion 2/6/2024Q4 2023$4.66$4.71+$0.05$8.00$8.13 billion$8.20 billion 10/31/2023Q3 2023$4.65$4.96+$0.31$6.70$6.92 billion$6.90 billion 8/3/2023Q2 2023$4.44$5.00+$0.56$7.43$6.66 billion$7.00 billion 4/27/2023Q1 2023$3.84$3.98+$0.14$2.68$6.18 billion$6.11 billion Get the Latest News and Ratings for AMGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amgen and its competitors with MarketBeat's FREE daily newsletter. 2/7/2023Q4 2022$4.04$4.09+$0.05$5.18$6.77 billion$6.84 billion 11/3/2022Q3 2022$4.43$4.70+$0.27$5.42$6.56 billion$6.65 billion 8/4/2022Q2 2022$4.40$4.65+$0.25$6.85$6.53 billion$6.59 billion 4/27/2022Q1 2022$4.22$4.25+$0.03$5.82$6.09 billion$6.24 billion 2/7/2022Q4 2021$4.14$4.36+$0.22$5.36$6.87 billion$6.85 billion 11/2/2021Q3 2021$4.22$4.67+$0.45$6.03$6.70 billion$6.71 billion 8/2/2021Q2 2021$4.09$4.38+$0.29$7.95$6.43 billion$6.53 billion 4/26/2021Q1 2021$4.05$3.70($0.35)$4.57$6.30 billion$5.90 billion 2/1/2021Q4 2020$3.39$3.81+$0.42$4.86$6.57 billion$6.63 billion 11/2/2020Q3 2020$3.75$4.37+$0.62$5.31$6.38 billion$6.42 billion 7/28/2020Q2 2020$3.81$4.25+$0.44$5.45$6.19 billion$6.21 billion 4/30/2020Q1 2020$3.70$4.17+$0.47$5.27$6.01 billion$6.16 billion 1/30/2020Q4 2019$3.47$3.64+$0.17$4.43$6.04 billion$6.20 billion 10/29/2019Q3 2019$3.53$3.66+$0.13$4.05$5.63 billion$5.74 billion Amgen Earnings - Frequently Asked Questions When is Amgen's earnings date? Amgen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, October 29th, 2024 based off last year's report dates. Learn more on AMGN's earnings history. What guidance has Amgen issued on next quarter's earnings? Amgen updated its FY 2024 earnings guidance on Tuesday, August, 6th. The company provided earnings per share (EPS) guidance of 19.100-20.100 for the period, compared to the consensus earnings per share estimate of 17.870. The company issued revenue guidance of $32.8 billion-$33.8 billion, compared to the consensus revenue estimate of $30.3 billion. Did Amgen beat their earnings estimates last quarter? In the previous quarter, Amgen (NASDAQ:AMGN) missed the analysts' consensus estimate of $5.01 by $0.04 with a reported earnings per share (EPS) of $4.97. Learn more on analysts' earnings estimate vs. AMGN's actual earnings. How can I listen to Amgen's earnings conference call? The conference call for Amgen's latest earnings report can be listened to online. Listen to Conference Call How can I read Amgen's conference call transcript? The conference call transcript for Amgen's latest earnings report can be read online. Read Transcript How much revenue does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded annual revenue of $30.93 billion. How much profit does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded net income of $6.72 billion. AMGN has generated $7.00 earnings per share over the last four quarters. What is Amgen's price-to-earnings ratio? Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 46.87 and a forward price-to-earnings ratio of 16.82. The price/earnings-to-growth ratio is 2.78. What is Amgen's EPS forecast for next year? Amgen's earnings are expected to grow from $19.50 per share to $20.61 per share in the next year, which is a 5.69% increase. More Earnings Resources from MarketBeat Related Companies: Regeneron Pharmaceuticals Earnings Results Vertex Pharmaceuticals Earnings Results Gilead Sciences Earnings Results Alnylam Pharmaceuticals Earnings Results Moderna Earnings Results Biogen Earnings Results BioMarin Pharmaceutical Earnings Results Neurocrine Biosciences Earnings Results United Therapeutics Earnings Results Incyte Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Target Hits the Mark: Q2 Earnings Exceed ExpectationsModerna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?Doximity: The 'Facebook for Doctors' Surges After Earnings BeatDeere Rebounds on Earnings Beat, But Uphill Battle RemainsWhy You Shouldn't Count Out Tencent Music Stock After EarningsHut 8 Corp.’s Earnings: Is Crypto Mining About to Change?Is NVIDIA Stock a Buy Ahead of Earnings? This page (NASDAQ:AMGN) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | SponsoredThe #1 A.I. Crypto You Don’t Own (YET!)Markets are volatile right now—stocks, cryptos, you name it. But here's a crucial fact everyone is missing:...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amgen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
